Emerging Cardiovascular Risk Factors That Account for a Significant Portion of Attributable Mortality Risk in Chronic Kidney Disease

This publication has 27 references indexed in Scilit:

• Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
  New England Journal of Medicine, 2006
• Testing the homocysteine hypothesis in end-stage renal disease: Problems and a possible solution
  Kidney International, 2006
• Homocysteine Trials — Clear Outcomes for Complex Reasons
  New England Journal of Medicine, 2006
• Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function
  American Heart Journal, 2006
• Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure
  JACC, 2006
• Amino Acid and Protein Kinetics in Renal Failure: An Integrated Approach
  Seminars in Nephrology, 2006
• Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
  Journal of the American Society of Nephrology, 2005
• Folate Therapy and In-Stent Restenosis after Coronary Stenting
  New England Journal of Medicine, 2004
• Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure
  Kidney International, 2003
• Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
  Circulation, 2003